Skip to content

Ligand Pharmaceuticals LGND Investment Purchases

Investment Purchases at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$50.9M+132%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$177.41M+85.8%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$192.76M-38.0%
ALN
Alnylam PharmaceuticalsALNY
$261.63M-34.9%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$8.85M-93.7%

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.51B+96.7%

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's investment purchases?
Ligand Pharmaceuticals (LGND) reported investment purchases of $222.18M in Q1 2026.
How has Ligand Pharmaceuticals's investment purchases changed year-over-year?
Ligand Pharmaceuticals's investment purchases increased by 274.2% year-over-year, from $59.37M to $222.18M.
What is the long-term trend for Ligand Pharmaceuticals's investment purchases?
Over 2 years (2021 to 2023), Ligand Pharmaceuticals's investment purchases has grown at a -100.0% compound annual growth rate (CAGR), from $181.33M to $0.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.